Database Query Results : Hydroxycinnamic-acid, ,

HCAs, Hydroxycinnamic-acid: Click to Expand ⟱

Features:

Hydroxycinnamic acid compounds (p-coumaric, caffeic acid (CA), ferulic acid) occur most frequently as simple esters with hydroxy carboxylic acids or glucose, while the hydroxybenzoic acid compounds (p-hydroxybenzoic, gallic acid, ellagic acid) are present mainly in the form of glucosides. https://www.sciencedirect.com/topics/chemistry/hydroxycinnamic-acid
Hydroxycinnamic acids (HCAs) are plant-derived phenolic acids (including caffeic, ferulic, p-coumaric, and sinapic acids) with documented antioxidant, anti-inflammatory (NF-κB↓), and context-dependent anticancer effects in cellular and preclinical models. Mechanistic themes include activation of the Nrf2/ARE antioxidant response, suppression of pro-inflammatory and survival pathways (such as NF-κB and PI3K/AKT), modulation of MAPK signaling, and downstream effects on cell-cycle, apoptosis, invasion, and angiogenesis. Oral exposure is influenced by rapid metabolism (phase II conjugates) and food matrix effects, which affects systemic bioavailability and translational relevance. Biological effects vary by specific hydroxycinnamic derivative and its conjugated/esterified form. (Caffeic acid ≠ ferulic acid ≠ sinapic acid)

-Ferulic acid and p‐coumaric acid are naturally occurring hydroxycinnamic acids found in many plant-based foods (such as whole grains, fruits, and vegetables)

CA showed pro-oxidant potential due to its ability to interact with metals like copper, inducing lipid peroxidation and causing DNA damage within tumor cells through either oxidation or covalent adduct formation.

Summary:
-HCAs are classically antioxidant
-Such as caffeic acid, ferulic acid, and sinapic acid (SA)
-May increase sensitivity to chemotherapy
-Bioavailability is problem. Formulation strategies (e.g., liposomal or encapsulated forms) are investigated to improve systemic exposure.
-Propolis has caffeic acid (Caffeic acid (0.639–4.172 mg/g propolis)
-SA at higher concentrations may acts as a potent pro-oxidant agent
-SA may act in collaboration with other chemotherapeutic agents to improve treatment sensitivity. -Co-administration of caffeic acid or CAPE with other anti-tumor compounds (e.g., gallic acid) has shown additive or synergistic effects in selected models
-Combination of caffeic acid and endogenous copper ions can result in oxidative damage
-Ferulic Acid (abundant in whole grains,popcorn): upregulate apoptotic protein and downregulate anti-apoptotic protein.upregulating (BAX), (p53), (CYCS) and downregulating (Bcl-2),

Rank	Pathway / Axis	Cancer Cells	Normal Cells	TSF	Primary Effect	Notes / Interpretation
1	Nrf2/ARE antioxidant response (Keap1-Nrf2-HO-1)	Stress adaptation modulation (context-dependent)	Nrf2 ↑; HO-1 & GSH systems ↑	R, G	Endogenous antioxidant upshift	Hydroxycinnamic acids commonly promote Nrf2 nuclear translocation and elevate antioxidant defense enzymes; this is one of the most consistent in vivo correlates.
2	NF-κB inflammatory transcription	NF-κB ↓; pro-inflammatory cytokine programs ↓ (reported)	Inflammation tone ↓; protective in injury models	R, G	Anti-inflammatory signaling	Hydroxycinnamic acids are widely reported to reduce NF-κB activity and downstream cytokine expression across inflammation and tumor models.
3	ROS / oxidative stress modulation	Oxidative stress ↓ (often); ROS direction variable	Oxidative injury ↓ in stress models	P, R, G	Redox buffering (context-dependent)	These acids are generally antioxidant, but in certain cancer models or at higher concentrations they may affect redox dynamics differentially.
4	Cell-cycle checkpoints (Cyclin D1/CDK4/6; checkpoints)	Cell-cycle arrest ↑ (reported); Cyclin/CDKs ↓	↔	G	Cytostasis	Largely late phenotype outcome linked to signaling changes.
5	Apoptosis (intrinsic/mitochondrial & caspase-linked)	Apoptosis ↑; caspase activation ↑ (reported)	↔ (less activation in normal contexts)	G	Cell death execution	Dependent on model and oxidative stress context; not as “direct” as classical mitochondrial toxins.
6	MAPK re-wiring (ERK / JNK / p38)	MAPK modulation (context-dependent)	↔	P, R, G	Signal reprogramming	Directions vary by tissue, stress levels, and derivative; avoid fixed arrows for all MAPKs unless model-specific evidence is provided.
7	PI3K → AKT (± mTOR) survival axis	PI3K/AKT modulation (reported)	↔	R, G	Survival/growth modulation	Often reported as downstream of NF-κB suppression and redox buffering.
8	Invasion / metastasis programs (MMPs / EMT)	MMPs ↓; migration-invasion ↓ (reported)	↔	G	Anti-invasive phenotype	Observed as downstream phenotypes; direction depends on specific hydroxycinnamic acid derivative.
9	Angiogenesis signaling (VEGF & angiogenic outputs)	VEGF ↓; angiogenesis markers ↓ (reported)	↔	G	Anti-angiogenic support	Later phenotype marker; linked to reduced pro-inflammatory and survival signaling.
10	Bioavailability / metabolism constraint (conjugation; food matrix dependence)	Systemic exposure variable; rapid conjugation	—	—	Translation constraint	Hydroxycinnamic acids are absorbed but rapidly metabolized (phase II conjugates); food matrix alters bioaccessibility and systemic exposure.

Time-Scale Flag (TSF): P / R / G

P: 0–30 min (primary/rapid effects; early redox interactions)
R: 30 min–3 hr (acute stress-response + transcription signaling shifts)
G: >3 hr (gene-regulatory adaptation and phenotype-level outcomes)

Scientific Papers found: Click to Expand⟱

1639-

Cu,

HCAs,

Green synthesis of copper oxide nanoparticles using sinapic acid: an underpinning step towards antiangiogenic therapy for breast cancer

in-vitro,

BC,

MCF-7

in-vitro,

BC,

MDA-MB-231

angioG↓, tumCV↓, Dose↓, ROS↑,

1642-

Cu,

HCAs,

Copper-assisted anticancer activity of hydroxycinnamic acid terpyridine conjugates on triple-negative breast cancer

in-vitro,

BC,

4T1

(IC50 ∼ 3.5 ± 2.5 μM

in-vitro,

Nor,

L929

IC50 ∼ 15 ± 5 μM

tumCV↓, selectivity↑,

602-

HCAs,

Prooxidant activity of hydroxycinnamic acids on DNA damage in the presence of Cu(II) ions: mechanism and structure-activity relationship

Analysis,

NA,

ROS↑, DNAdam↑,

1638-

HCAs,

Anticancer potential of hydroxycinnamic acids: mechanisms, bioavailability, and therapeutic applications

Review,

Nor,

*BioAv↓, Inflam↓, COX2↓, TumCCA↑, ChemoSen↑, RadioS↑, selectivity↑, ROS↑, DNAdam↑, antiOx↑, SOD↑, Catalase↑, GPx↑, GSH↑, NRF2↑, NF-kB↓, Cyc↓, CDK1↑, P21↑, p27↑, P53↑, VEGF↓, MAPK↓,

1641-

HCAs,

Lung cancer induced by Benzo(A)Pyrene: ChemoProtective effect of sinapic acid in swiss albino mice

in-vitro,

Lung,

A549

50 µM

in-vivo,

Lung,

mice

AntiCan↑, Igs↓, lipid-P↓, ROS↑, Casp3↑, Casp9↑, ChemoSideEff↓, Dose∅,

1643-

HCAs,

Mechanisms involved in the anticancer effects of sinapic acid

Review,

Var,

*BioAv↓, *toxicity↓, Dose∅, ROS⇅, ROS↑, Igs↑, TumCCA↑, TumAuto↑, eff↑, angioG↓, TumCI↓, TumMeta↓, EMT↓, Vim↓, MMP9↓, MMP2↓, Snail↓, E-cadherin↑, p‑Akt↓, GSK‐3β↓, TumCP↓, ChemoSen↑,

1644-

HCAs,

PBG,

Artepillin C (3,5-diprenyl-4-hydroxycinnamic acid) sensitizes LNCaP prostate cancer cells to TRAIL-induced apoptosis

in-vitro,

Pca,

LNCaP

NF-kB↓, TRAILR↑, Casp8↑, Casp3↑, MMP↓, Dose?,

1645-

HCAs,

Chapter 8 - Hydroxycinnamic Acids: Natural Sources, Biosynthesis, Possible Biological Activities, and Roles in Islamic Medicine

Review,

Nor,

Dose∅, ROS⇅, Dose∅,

1649-

HCAs,

Anticancer Properties of Hydroxycinnamic Acids -A Review

Review,

Var,

*antiOx↑, MMP2↓, MMP9↓, VEGF↓, TGF-β↓, Bax:Bcl2↑, TumCCA↑, COX2↓, NF-kB↓,

1657-

HCAs,

Anticancer Activity of Sinapic Acid by Inducing Apoptosis in HT-29 Human Colon Cancer Cell Line 2023

in-vitro,

CRC,

HT-29

200 μM

317.5 μM for 24 hours

cl‑Casp3↑, BAX↑, cl‑PARP↑, γH2AX↑, Cyt‑c↑,

2400-

HCAs,

The Mixture of Ferulic Acid and P-Coumaric Acid Suppresses Colorectal Cancer through lncRNA 495810/PKM2 Mediated Aerobic Glycolysis

in-vitro,

CRC,

in-vivo,

CRC,

mice

PKM2↓, Glycolysis↓, TumCG↓,

2407-

HCAs,

2'-hydroxycinnamaldehyde inhibits cancer cell proliferation and tumor growth by targeting the pyruvate kinase M2

in-vitro,

Pca,

DU145

in-vitro,

Pca,

LNCaP

p‑PKM2↓, TumCG↓,

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 12

Pathway results for Effect on Cancer / Diseased Cells:

Functional Outcomes ⓘ

AntiCan↑, 1, ChemoSideEff↓, 1,
Total Targets: 62

Pathway results for Effect on Normal Cells:

Redox & Oxidative Stress ⓘ

antiOx↑, 1,

Drug Metabolism & Resistance ⓘ

BioAv↓, 2,

Functional Outcomes ⓘ

toxicity↓, 1,
Total Targets: 3

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:95  Target#:%  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

Database Query Results : Hydroxycinnamic-acid, ,

Pathway results for Effect on Cancer / Diseased Cells:

Redox & Oxidative Stress ⓘ

Mitochondria & Bioenergetics ⓘ

Core Metabolism/Glycolysis ⓘ

Cell Death ⓘ

Transcription & Epigenetics ⓘ

Autophagy & Lysosomes ⓘ

DNA Damage & Repair ⓘ

Cell Cycle & Senescence ⓘ

Proliferation, Differentiation & Cell State ⓘ

Migration ⓘ

Angiogenesis & Vasculature ⓘ

Immune & Inflammatory Signaling ⓘ

Drug Metabolism & Resistance ⓘ

Functional Outcomes ⓘ

Pathway results for Effect on Normal Cells:

Redox & Oxidative Stress ⓘ

Drug Metabolism & Resistance ⓘ

Functional Outcomes ⓘ

Home Page